Global Dry Powder Inhaler Device Market Professional Survey Report 2019 (Updated April)

Global Dry Powder Inhaler Device Market Professional Survey Report 2019 (Updated April)

Press Release

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema, and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

The global total sales of dry powder inhaler device are nearly 49674 K units.
As a high tech industry, the manufacturing technology of Dry Powder Inhaler Device is mature but only these international giants can supply the high-end products with excellent performance. There is still a core technical barrier.

Today, the price of Dry Powder Inhaler Device is lower than in past years. The reason for this downward trend of price is the development of technology and the price fluctuations of raw materials. In the future, the price would go down continuously and slowly.

The global Dry Powder Inhaler Device market is valued at 640 million US$ in 2017 and will reach 900 million US$ by the end of 2025, growing at a CAGR of 4.9% during 2019-2025.

Global Dry Powder Inhaler Device Market Professional Survey Report 2019 (Updated April) is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets in this 125 pages report.

This market report provides in-depth analytics of the Dry Powder Inhaler Device industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Dry Powder Inhaler Device research report

Dry Powder Inhaler Device market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Meda
Novartis
Schering/Merck
Teva
Vectura

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Single Dose
Multi-dose

By Industrial Application, the market can be split into:

Asthma
COPD
Other

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Dry Powder Inhaler Device Market Professional Survey Report 2019 (Updated April)

Contacts

Trusted Business Insights
Shelly Arnold
Blogger & Influencer Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , ,